BIOMAT Database Logo BIOMAT Database Logo

[5-methyl-3-phenyl-4-isoxazolyl-penicillin: antibacterial activity in vitro; serum and urinary concentrations]. 1968

S Sanguigni, and R Rapisarda, and C Gargiulo, and F Marchio

UI MeSH Term Description Entries
D010068 Oxacillin An antibiotic similar to FLUCLOXACILLIN used in resistant staphylococci infections. Oxazocilline,Penicillin, Methylphenylisoxazolyl,Sodium Oxacillin,Oxacillin Sodium,Oxacillin, Monosodium Salt, Anhydrous,Oxacillin, Monosodium Salt, Monohydrate,Prostaphlin,Methylphenylisoxazolyl Penicillin,Oxacillin, Sodium,Sodium, Oxacillin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

S Sanguigni, and R Rapisarda, and C Gargiulo, and F Marchio
[Study of the antibacterial activity in vitro of 5-methyl-3-phenyl-4-isoxazolyl-penicillin].
December 1966, La Clinica terapeutica,
S Sanguigni, and R Rapisarda, and C Gargiulo, and F Marchio
[5-Methyl-3-phenyl-4-isoxazolyl-penicillin].
July 1962, Arzneimittel-Forschung,
S Sanguigni, and R Rapisarda, and C Gargiulo, and F Marchio
Antistaphylococcal activity of penicillin P-12. (5-Methyl-3-phenyl-4-isoxazolyl penicillin).
February 1962, The American journal of the medical sciences,
S Sanguigni, and R Rapisarda, and C Gargiulo, and F Marchio
Microbiological evaluation of 5-methyl-3-phenyl-4-isoxazolyl penicillin.
December 1961, Antibiotics & chemotherapy (Northfield, Ill.),
S Sanguigni, and R Rapisarda, and C Gargiulo, and F Marchio
[5-METHYL-3-PHENYL-4-ISOXAZOLYL PENICILLIN (OXACILLIN) AND ITS MICROBIOLOGICAL INVESTIGATION].
November 1963, Antibiotiki,
S Sanguigni, and R Rapisarda, and C Gargiulo, and F Marchio
Clinical evaluation of 5-methyl-3-phenyl-4-isoxazolyl penicillin in staphylococcal infections.
April 1962, The New England journal of medicine,
S Sanguigni, and R Rapisarda, and C Gargiulo, and F Marchio
[In vitro and in vivo studies on a new oral synthetic penicillin, 5-methyl-3-phenyl-4-isoxazolyl penicillin].
January 1962, Canadian Medical Association journal,
S Sanguigni, and R Rapisarda, and C Gargiulo, and F Marchio
[5-Methyl-3-phenyl-4-isoxazolyl penicillin in infections produced by staphylococcus producing penicillinase].
January 1966, Revista de la Facultad de Medicina, Universidad Nacional de Colombia,
S Sanguigni, and R Rapisarda, and C Gargiulo, and F Marchio
[CLINICAL CONSIDERATIONS ON A NEW SEMISYNTHETIC PENICILLIN (5-METHYL-3-PHENYL-4-ISOXAZOLYL-PENICILLIN OR OXACILLIN)].
June 1964, La Riforma medica,
S Sanguigni, and R Rapisarda, and C Gargiulo, and F Marchio
Preliminary clinical and laboratory experiences with a new oral penicillin: 5-methyl-3-phenyl-4-isoxazolyl penicillin.
February 1962, Proceedings of the staff meetings. Mayo Clinic,
Copied contents to your clipboard!